• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Acceptance address, Dr Luis Pizarro – 2023 Princess of Asturias Awards Ceremony

Home > News

Acceptance address, Dr Luis Pizarro – 2023 Princess of Asturias Awards Ceremony

Dr Luis Pizarro at the Ceremony of the Princess Asturias Awards 2023
Dr Luis Pizarro giving his acceptance address at the ceremony.
Oviedo, España — 20 Oct 2023
  • English
    • English
    • Español
    • Français
watch dr luis pizarro’s acceptance address

‘Your Majesties, Your Royal Highnesses, distinguished members of the jury, distinguished award winners, respected authorities, ladies and gentlemen,

To be honest, in an ideal world, I would not be here with you today – because, of course, in an ideal world, no sick person would be ignored, and DNDi would have no reason to exist.

Yet, there are millions. Millions of people – neglected, forgotten, invisible – affected by often fatal diseases for which there are no medicines that can cure them. They are simply too poor for their illnesses to be of any interest on this side of the world.

Like Amasi, an 18-year-old Sudanese girl, infected with mycetoma, a tissue-destroying disease that many children in her village contract by walking barefoot on infected thorns. Amputation is often the only solution. Amasi was wheelchair-bound, not responding well to medication – and today, we have no more news of her.

Or consider Bimal, an Indian worker living with HIV and a disease called leishmaniasis. In Spain we know the disease because it affects dogs, but in many countries, it affects people. Bimal can no longer work because of his illness, which has plunged his family into poverty and forced his 14-year-old son to drop out of school to find a job to feed his parents and siblings. 

These are just two examples, among many others, of diseases that kill and disfigure, and that devastate not only those who fall ill, but also their communities and loved ones.

Neglected diseases affect one in five people on our planet – that’s 1.6 billion people who suffer from one of them every year.

Many are appearing in new regions, especially due to climate change and population movements. In Spain, for example, there are now patients with Chagas disease and increasing cases of dengue fever.

Chagas disease will soon be one of the main causes of heart transplantation in Spain. Existing treatments are not satisfactory, and only 1% of people with Chagas receive them.

Yet, this unacceptable situation is not inevitable. Today, we can choose not to ignore these patients.

Indeed, look at COVID-19. The pandemic has shown us what feats science can achieve with a bit of political will. In less than a year, vaccines were invented for a disease that did not even exist years before.

The only reason the people we serve are deprived of the fruits of medical innovation is that they were born in the wrong place.

They are overlooked by traditional pharmaceutical research because they are too poor to constitute a lucrative market, and they are neglected by political decision-makers because their voices are not heard, because poverty pushes them to the fringes of society.

But I am not here to preach. On the contrary, I am here to share a message of hope.

Working closely with partners around the world, especially in affected countries, our organization has succeeded in developing 12 new treatments for neglected patients.

It is no exaggeration to say: together we have saved millions of lives.

Together, we are proving that a non-profit model of research and development, centred on patients’ needs, is possible.

That is why I would like to warmly thank the Princess of Asturias Foundation for this award, which represents a great loudspeaker to call attention to this issue. It is heartening to know that global health matters are crucial to the Jury and their Majesties, who have already recognized institutions such as the WHO with this award. Thank you from the bottom of our hearts.

Let me conclude with the story of Brinol, a 12-year-old Congolese boy. Last April, Brinol was diagnosed with sleeping sickness.

It is a terrible disease that, if left untreated, inevitably leads to death. Twenty years ago, when DNDi was founded, the available treatment involved injections of an arsenic-based drug that was so toxic it killed one in 20 patients.

At DNDi, with all our partners, we developed a simple, safe, and effective pill. Brinol took it for 10 days at home. Today, Brinol is healthy, happy, cured of the disease, and dreaming of becoming a mechanic like his father.

Beyond Brinol’s case, thanks to the introduction of this simple treatment, we can now contemplate eliminating sleeping sickness globally.

I have come to Oviedo, to this beautiful Asturian land, to tell you that today, in 2023, thanks to advances in science, the work of our teams and partners, and the attention you are giving us with this award, we can, together, put an end to neglected diseases.

Thank you all.’

Photo credits: Fundación Princesa de Asturias

Europe Spain

Read, watch, share

Loading...
Press releases
22 May 2025

Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis

Videos
20 May 2025

The Children of the Sierra

Statements
19 May 2025

DNDi interventions at the 78th World Health Assembly

Press releases
13 May 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License